ABCLVSLTRN• 6 Months (Normalized)
ABCL vs LTRN (AbCellera Biologics Inc. vs Lantern Pharma Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABCL Performance $10.89
+205.9%
AbCellera Biologics Inc.
Normalized Baseline0.00%
LTRN Performance $1.71
-29.05%
Lantern Pharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin ABCL LEADS
+234.95%
ABCL outperforming by 234.95%
ABCLLTRN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABCL LTRN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | ABCL Price | ABCL Gain (%) | LTRN Price | LTRN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $10.89 | +205.90% | $1.71 | -29.05% | +234.95% |
| Sep 10, 2026 | $10.46 | +193.82% | $1.76 | -26.97% | +220.79% |
| Sep 09, 2026 | $11.05 | +210.39% | $1.77 | -26.56% | +236.95% |
| Sep 08, 2026 | $11.44 | +221.35% | $1.84 | -23.65% | +245.00% |
| Sep 04, 2026 | $11.43 | +221.07% | $1.91 | -20.95% | +242.02% |
| Sep 03, 2026 | $11.57 | +225.00% | $1.87 | -22.41% | +247.41% |
| Sep 02, 2026 | $11.36 | +219.10% | $1.93 | -19.92% | +239.02% |
| Sep 01, 2026 | $11.28 | +216.85% | $2.02 | -16.18% | +233.03% |
| Aug 31, 2026 | $11.48 | +222.47% | $2.03 | -15.77% | +238.24% |
| Aug 28, 2026 | $11.35 | +218.82% | $2.07 | -14.11% | +232.93% |
| Aug 27, 2026 | $12.40 | +248.31% | $2.16 | -10.37% | +258.68% |
| Aug 26, 2026 | $12.24 | +243.82% | $2.18 | -9.54% | +253.36% |
| Aug 25, 2026 | $12.50 | +251.12% | $2.18 | -9.54% | +260.66% |
| Aug 24, 2026 | $10.61 | +198.03% | $2.11 | -12.45% | +210.48% |
| Aug 21, 2026 | $11.32 | +217.98% | $2.34 | -2.90% | +220.88% |
Page 1 of 9